{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:07:55Z","timestamp":1789376875203,"version":"build-2803163510"},"reference-count":70,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cyclopentenone prostaglandins are potent inhibitors of nuclear factor-\u03baB (NF-\u03baB), a transcription factor with a critical role in promoting inflammation and connected with multiple aspects of oncogenesis and cancer cell survival. In the present report, we investigated the role of NF-\u03baB in the antineoplastic activity of the cyclopentenone prostaglandin 15-deoxy-\u039412,14-PGJ2 (15d-PGJ2) in multiple myeloma (MM) and Burkitt lymphoma (BL) cells expressing constitutively active NF-\u03baB. 15d-PGJ2 was found to suppress constitutive NF-\u03baB activity and potently induce apoptosis in both types of B-cell malignancies. 15d-PGJ2-induced apoptosis occurs through multiple caspase activation pathways involving caspase-8 and caspase-9, and is prevented by pretreatment with the pan-caspase inhibitor ZVAD (z-Val-Ala-Asp). NF-\u03baB inhibition is accompanied by rapid down-regulation of NF-\u03baB-dependent antiapoptotic gene products, including cellular inhibitor-of-apoptosis protein 1 (cIAP-1), cIAP-2, X-chromosome-linked inhibitor-of-apoptosis protein (XIAP), and FLICE-inhibitory protein (cFLIP). These effects were mimicked by the proteasome inhibitor MG-132, but not by the peroxisome proliferator-activated receptor-\u03b3 (PPAR-\u03b3) agonist troglitazone, suggesting that 15d-PGJ2-induced apoptosis is independent of PPAR-\u03b3. Knockdown of the NF-\u03baB p65-subunit by lentiviral-mediated shRNA interference also resulted in apoptosis induction in malignant B cells with constitutively active NF-\u03baB. The results indicate that inhibition of NF-\u03baB plays a major role in the proapoptotic activity of 15d-PGJ2 in aggressive B-cell malignancies characterized by aberrant regulation of NF-\u03baB. (Blood. 2005;105:1750-1758)<\/jats:p>","DOI":"10.1182\/blood-2004-04-1360","type":"journal-article","created":{"date-parts":[[2004,10,22]],"date-time":"2004-10-22T00:24:52Z","timestamp":1098404692000},"page":"1750-1758","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":75,"title":["15-Deoxy-\u039412,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-\u03baB activity and down-regulation of antiapoptotic proteins"],"prefix":"10.1182","volume":"105","author":[{"given":"Roberto","family":"Piva","sequence":"first","affiliation":[{"name":"From the Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, Rome, Italy; and the Department of Pathology and Center for Experimental Research and Medical Studies (CERMS), University of Turin, Turin, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Gianferretti","sequence":"additional","affiliation":[{"name":"From the Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, Rome, Italy; and the Department of Pathology and Center for Experimental Research and Medical Studies (CERMS), University of Turin, Turin, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ciucci","sequence":"additional","affiliation":[{"name":"From the Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, Rome, Italy; and the Department of Pathology and Center for Experimental Research and Medical Studies (CERMS), University of Turin, Turin, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Taulli","sequence":"additional","affiliation":[{"name":"From the Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, Rome, Italy; and the Department of Pathology and Center for Experimental Research and Medical Studies (CERMS), University of Turin, Turin, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Belardo","sequence":"additional","affiliation":[{"name":"From the Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, Rome, Italy; and the Department of Pathology and Center for Experimental Research and Medical Studies (CERMS), University of Turin, Turin, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Gabriella","family":"Santoro","sequence":"additional","affiliation":[{"name":"From the Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, Rome, Italy; and the Department of Pathology and Center for Experimental Research and Medical Studies (CERMS), University of Turin, Turin, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218073164000_REF1","doi-asserted-by":"crossref","unstructured":"Straus DS, Glass CK. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev.2001;21: 185-210.","DOI":"10.1002\/med.1006"},{"key":"2020021218073164000_REF2","doi-asserted-by":"crossref","unstructured":"Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med.1999;5: 698-701.","DOI":"10.1038\/9550"},{"key":"2020021218073164000_REF3","doi-asserted-by":"crossref","unstructured":"Santoro MG. Antiviral activity of cyclopentenone prostanoids. Trends Microbiol.1997;5: 276-281.","DOI":"10.1016\/S0966-842X(97)01066-4"},{"key":"2020021218073164000_REF4","doi-asserted-by":"crossref","unstructured":"Santoro MG, Benedetto A, Jaffe BM. Prostaglandin A1 induces differentiation in Friend erythroleukemia cells. Prostaglandins.1979;17: 719-727.","DOI":"10.1016\/S0090-6980(79)80043-X"},{"key":"2020021218073164000_REF5","unstructured":"Santoro MG, Crisari A, Benedetto A, Amici C. Modulation of the growth of a human erythroleukemic cell line (K562) by prostaglandins: antiproliferative action of prostaglandin A. Cancer Res.1986;46: 6073-6077."},{"key":"2020021218073164000_REF6","doi-asserted-by":"crossref","unstructured":"Clay CE, Namen AM, Atsumi G, et al. Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. Carcinogenesis.1999;20: 1905-1911.","DOI":"10.1093\/carcin\/20.10.1905"},{"key":"2020021218073164000_REF7","unstructured":"Butler R, Mitchell SH, Tindall DJ, Young CY. Non-apoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2. Cell Growth Differ.2000;11: 49-61."},{"key":"2020021218073164000_REF8","doi-asserted-by":"crossref","unstructured":"Shimada T, Kojima K, Yoshiura K, Hiraishi H, Terano A. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells. Gut.2002;50: 658-664.","DOI":"10.1136\/gut.50.5.658"},{"key":"2020021218073164000_REF9","doi-asserted-by":"crossref","unstructured":"Tsubouchi Y, Sano H, Kawahito Y, et al. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem Biophys Res Commun.2000;270: 400-405.","DOI":"10.1006\/bbrc.2000.2436"},{"key":"2020021218073164000_REF10","doi-asserted-by":"crossref","unstructured":"Zander T, Kraus JA, Grommes C, et al. Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma. J Neurochem.2002;81: 1052-1060.","DOI":"10.1046\/j.1471-4159.2002.00899.x"},{"key":"2020021218073164000_REF11","doi-asserted-by":"crossref","unstructured":"Liu JD, Lin SY, Ho YS, et al. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells. Mol Carcinog.2003;37: 16-24.","DOI":"10.1002\/mc.10119"},{"key":"2020021218073164000_REF12","doi-asserted-by":"crossref","unstructured":"Mossner R, Schulz U, Kruger U, et al. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma. J Invest Dermatol.2002;119: 576-582.","DOI":"10.1046\/j.1523-1747.2002.01861.x"},{"key":"2020021218073164000_REF13","doi-asserted-by":"crossref","unstructured":"Laurora S, Pizzimenti S, Briatore F, et al. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. J Pharmacol Exp Ther.2003;305: 932-942.","DOI":"10.1124\/jpet.103.049098"},{"key":"2020021218073164000_REF14","doi-asserted-by":"crossref","unstructured":"Padilla J, Leung E, Phipps RP. Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. Clin Immunol.2002;103: 22-33.","DOI":"10.1006\/clim.2001.5181"},{"key":"2020021218073164000_REF15","doi-asserted-by":"crossref","unstructured":"Nencioni A, Lauber K, Grunebach F, et al. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling. J Immunol.2003;171: 5148-5156.","DOI":"10.4049\/jimmunol.171.10.5148"},{"key":"2020021218073164000_REF16","doi-asserted-by":"crossref","unstructured":"Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell.1995;83: 813-819.","DOI":"10.1016\/0092-8674(95)90194-9"},{"key":"2020021218073164000_REF17","doi-asserted-by":"crossref","unstructured":"Boyault S, Simonin MA, Bianchi A, et al. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways. FEBS Lett.2001;501: 24-30.","DOI":"10.1016\/S0014-5793(01)02614-X"},{"key":"2020021218073164000_REF18","doi-asserted-by":"crossref","unstructured":"Ward C, Dransfield I, Murray J, Farrow SN, Haslett C, Rossi AG. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. J Immunol.2002;168: 6232-6243.","DOI":"10.4049\/jimmunol.168.12.6232"},{"key":"2020021218073164000_REF19","doi-asserted-by":"crossref","unstructured":"Rossi A, Kapahi P, Natoli G, et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature.2000;403: 103-108.","DOI":"10.1038\/47520"},{"key":"2020021218073164000_REF20","doi-asserted-by":"crossref","unstructured":"Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol.2002;2: 725-734.","DOI":"10.1038\/nri910"},{"key":"2020021218073164000_REF21","doi-asserted-by":"crossref","unstructured":"Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol.2002;3: 221-227.","DOI":"10.1038\/ni0302-221"},{"key":"2020021218073164000_REF22","doi-asserted-by":"crossref","unstructured":"Santoro MG, Rossi A, Amici C. NF-kappaB and virus infection: who controls whom. Embo J.2003;22: 2552-2560.","DOI":"10.1093\/emboj\/cdg267"},{"key":"2020021218073164000_REF23","doi-asserted-by":"crossref","unstructured":"Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-\u03baB activity. Annu Rev Immunol.2000;18: 621-663.","DOI":"10.1146\/annurev.immunol.18.1.621"},{"key":"2020021218073164000_REF24","doi-asserted-by":"crossref","unstructured":"Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer.2002;2: 301-310.","DOI":"10.1038\/nrc780"},{"key":"2020021218073164000_REF25","doi-asserted-by":"crossref","unstructured":"Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol.1999;19: 5785-5799.","DOI":"10.1128\/MCB.19.8.5785"},{"key":"2020021218073164000_REF26","doi-asserted-by":"crossref","unstructured":"Duyao MP, Kessler DJ, Spicer DB, et al. Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B. J Biol Chem.1992;267: 16288-16291.","DOI":"10.1016\/S0021-9258(18)41998-9"},{"key":"2020021218073164000_REF27","doi-asserted-by":"crossref","unstructured":"Rayet B, Gelinas C. Aberrant rel\/nfkb genes and activity in human cancer. Oncogene.1999;18: 6938-6947.","DOI":"10.1038\/sj.onc.1203221"},{"key":"2020021218073164000_REF28","doi-asserted-by":"crossref","unstructured":"Baldwin AS Jr. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest.2001;107: 3-6.","DOI":"10.1172\/JCI11891"},{"key":"2020021218073164000_REF29","doi-asserted-by":"crossref","unstructured":"Bargou RC, Emmerich F, Krappmann D, et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest.1997;100: 2961-2969.","DOI":"10.1172\/JCI119849"},{"key":"2020021218073164000_REF30","doi-asserted-by":"crossref","unstructured":"Pham LV, Tamayo AT, Yoshimura LC, et al. A CD40 signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas. Immunity.2002;16: 37-50.","DOI":"10.1016\/S1074-7613(01)00258-8"},{"key":"2020021218073164000_REF31","doi-asserted-by":"crossref","unstructured":"Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med.2001; 194: 1861-1874.","DOI":"10.1084\/jem.194.12.1861"},{"key":"2020021218073164000_REF32","doi-asserted-by":"crossref","unstructured":"Ni H, Ergin M, Huang Q, et al. Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis. Br J Haematol.2001;115: 279-286.","DOI":"10.1046\/j.1365-2141.2001.03102.x"},{"key":"2020021218073164000_REF33","unstructured":"Orlowski RZ, Eswara JR, Lafond-Walker A, Grever MR, Orlowski M, Dang CV. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor. Cancer Res.1998;58: 4342-4348."},{"key":"2020021218073164000_REF34","doi-asserted-by":"crossref","unstructured":"Tiscornia G, Tergaonkar V, Galimi F, Verma IM. CRE recombinase-inducible RNA interference mediated by lentiviral vectors. Proc Natl Acad Sci U S A.2004;101: 7347-7351.","DOI":"10.1073\/pnas.0402107101"},{"key":"2020021218073164000_REF35","doi-asserted-by":"crossref","unstructured":"Zabel U, Schreck R, Baeuerle PA. DNA binding of purified transcription factor NF-kappa B: affinity, specificity, Zn2+ dependence, and differential halfsite recognition. J Biol Chem.1991;266: 252-260.","DOI":"10.1016\/S0021-9258(18)52428-5"},{"key":"2020021218073164000_REF36","doi-asserted-by":"crossref","unstructured":"Mosser DD, Theodorakis NG, Morimoto RI. Coordinate changes in heat shock element-binding activity and HSP70 gene transcription rates in human cells. Mol Cell Biol.1988;8: 4736-4744.","DOI":"10.1128\/MCB.8.11.4736"},{"key":"2020021218073164000_REF37","doi-asserted-by":"crossref","unstructured":"DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature.1997;388: 548-554.","DOI":"10.1038\/41493"},{"key":"2020021218073164000_REF38","doi-asserted-by":"crossref","unstructured":"Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol.1998;16: 225-260.","DOI":"10.1146\/annurev.immunol.16.1.225"},{"key":"2020021218073164000_REF39","doi-asserted-by":"crossref","unstructured":"Rossi A, Elia G, Santoro MG. Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. Proc Natl Acad Sci U S A.1997;94: 746-750.","DOI":"10.1073\/pnas.94.2.746"},{"key":"2020021218073164000_","doi-asserted-by":"crossref","unstructured":"Straus DS, Pascual G, Li M, et al. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A.2000;97: 4844-4849.","DOI":"10.1073\/pnas.97.9.4844"},{"key":"2020021218073164000_REF41","doi-asserted-by":"crossref","unstructured":"Amici C, Belardo G, Rossi A, Santoro MG. Activation of I kappa B kinase by herpes simplex virus type 1: a novel target for anti-herpetic therapy. J Biol Chem.2001;276: 28759-28766.","DOI":"10.1074\/jbc.M103408200"},{"key":"2020021218073164000_REF42","doi-asserted-by":"crossref","unstructured":"Rovin BH, Lu L, Cosio A. Cyclopentenone prostaglandins inhibit cytokine-induced NF-kappaB activation and chemokine production by human mesangial cells. J Am Soc Nephrol.2001;12: 1659-1667.","DOI":"10.1681\/ASN.V1281659"},{"key":"2020021218073164000_REF43","doi-asserted-by":"crossref","unstructured":"Rossi A, Elia G, Santoro MG. 2-Cyclopenten-1-one, a new inducer of heat shock protein 70 with antiviral activity. J Biol Chem.1996;271: 32192-32196.","DOI":"10.1074\/jbc.271.50.32192"},{"key":"2020021218073164000_REF44","doi-asserted-by":"crossref","unstructured":"Mitsiades N, Mitsiades CS, Poulaki V, et al. Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications. Blood.2002;99: 4079-4086.","DOI":"10.1182\/blood.V99.11.4079"},{"key":"2020021218073164000_REF45","doi-asserted-by":"crossref","unstructured":"Chen Y, Morrow JD, Roberts LJ II. Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway. J Biol Chem.1999;274: 10863-10868.","DOI":"10.1074\/jbc.274.16.10863"},{"key":"2020021218073164000_REF46","doi-asserted-by":"crossref","unstructured":"Roberts LJ II, Morrow JD. Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation. Cell Mol Life Sci.2002;59: 808-820.","DOI":"10.1007\/s00018-002-8469-8"},{"key":"2020021218073164000_REF47","doi-asserted-by":"crossref","unstructured":"Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature.1995;376: 167-170.","DOI":"10.1038\/376167a0"},{"key":"2020021218073164000_REF48","unstructured":"Kessler DJ, Spicer DB, La Rosa FA, Sonenshein GE. A novel NF-kappa B element within exon 1 of the murine c-myc gene. Oncogene.1992;7: 2447-2453."},{"key":"2020021218073164000_REF49","doi-asserted-by":"crossref","unstructured":"La Rosa FA, Pierce JW, Sonenshein GE. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors. Mol Cell Biol.1994;14: 1039-1044.","DOI":"10.1128\/MCB.14.2.1039"},{"key":"2020021218073164000_REF50","doi-asserted-by":"crossref","unstructured":"Kanda K, Hu HM, Zhang L, Grandchamps J, Boxer LM. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer. J Biol Chem.2000;275: 32338-32346.","DOI":"10.1074\/jbc.M004148200"},{"key":"2020021218073164000_REF51","doi-asserted-by":"crossref","unstructured":"Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS. Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood.1999;93: 3044-3052.","DOI":"10.1182\/blood.V93.9.3044"},{"key":"2020021218073164000_REF52","unstructured":"Hideshima T, Richardson P, Chauhan D, et al. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res.2001;61: 3071-3076."},{"key":"2020021218073164000_","doi-asserted-by":"crossref","unstructured":"Hideshima T, Chauhan D, Richardson P, et al. NF-kappa B as a therapeutic target in multiple myeloma. J Biol Chem.2002;277: 16639-16647.","DOI":"10.1074\/jbc.M200360200"},{"key":"2020021218073164000_REF54","doi-asserted-by":"crossref","unstructured":"Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood.2003;101: 1053-1062.","DOI":"10.1182\/blood-2002-05-1320"},{"key":"2020021218073164000_REF55","doi-asserted-by":"crossref","unstructured":"Padilla J, Kaur K, Cao HJ, Smith TJ, Phipps RP. Peroxisome proliferator activator receptorgamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells. J Immunol.2000;165: 6941-6948.","DOI":"10.4049\/jimmunol.165.12.6941"},{"key":"2020021218073164000_REF56","doi-asserted-by":"crossref","unstructured":"Clay CE, Monjazeb A, Thorburn J, Chilton FH, High KP. 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells. J Lipid Res.2002;43: 1818-1828.","DOI":"10.1194\/jlr.M200224-JLR200"},{"key":"2020021218073164000_REF57","doi-asserted-by":"crossref","unstructured":"Nikitakis NG, Siavash H, Hebert C, Reynolds MA, Hamburger AW, Sauk JJ. 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells. Br J Cancer.2002;87: 1396-1403.","DOI":"10.1038\/sj.bjc.6600618"},{"key":"2020021218073164000_REF58","doi-asserted-by":"crossref","unstructured":"Nencioni A, Lauber K, Grunebach F, et al. Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli. Exp Hematol.2002;30: 1020-1028.","DOI":"10.1016\/S0301-472X(02)00877-9"},{"key":"2020021218073164000_REF59","doi-asserted-by":"crossref","unstructured":"Mitsiades N, Mitsiades CS, Poulaki V, et al. Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc Natl Acad Sci U S A.2002;99: 14374-14379.","DOI":"10.1073\/pnas.202445099"},{"key":"2020021218073164000_REF60","doi-asserted-by":"crossref","unstructured":"Hideshima T, Mitsiades C, Akiyama M, et al. Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341. Blood.2003;101: 1530-1534.","DOI":"10.1182\/blood-2002-08-2543"},{"key":"2020021218073164000_REF61","doi-asserted-by":"crossref","unstructured":"Hideshima T, Richardson P, Anderson KC. Novel therapeutic approaches for multiple myeloma. Immunol Rev.2003;194: 164-176.","DOI":"10.1034\/j.1600-065X.2003.00053.x"},{"key":"2020021218073164000_REF62","unstructured":"Cherney BW, Bhatia KG, Sgadari C, et al. Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells. Cancer Res.1997;57: 2508-2515."},{"key":"2020021218073164000_REF63","doi-asserted-by":"crossref","unstructured":"Liu Q, Hilsenbeck S, Gazitt Y. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2\/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2\/TRAIL. Blood.2003;101: 4078-4087.","DOI":"10.1182\/blood-2002-10-3231"},{"key":"2020021218073164000_REF64","doi-asserted-by":"crossref","unstructured":"Lee JH, Kim HS, Jeong SY, Kim IK. Induction of p53 and apoptosis by delta 12-PGJ2 in human hepatocarcinoma SK-HEP-1 cells. FEBS Lett.1995;368: 348-352.","DOI":"10.1016\/0014-5793(95)00703-C"},{"key":"2020021218073164000_REF65","doi-asserted-by":"crossref","unstructured":"Ohtani-Fujita N, Minami S, Mimaki S, Dao S, Sakai T. p53-Independent activation of the gadd45 promoter by Delta12-prostaglandin J2. Biochem Biophys Res Commun.1998;251: 648-652.","DOI":"10.1006\/bbrc.1998.9511"},{"key":"2020021218073164000_REF66","doi-asserted-by":"crossref","unstructured":"Donato NJ, Wu JY, Zhang L, Kantarjian H, Talpaz M. Down-regulation of interleukin-3\/granulocyte-macrophage colony-stimulating factor receptor beta-chain in BCR-ABL(+) human leukemic cells: association with loss of cytokine-mediated Stat-5 activation and protection from apoptosis after BCR-ABL inhibition. Blood.2001;97: 2846-2853.","DOI":"10.1182\/blood.V97.9.2846"},{"key":"2020021218073164000_REF67","doi-asserted-by":"crossref","unstructured":"Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol.2002;4: E131-E136.","DOI":"10.1038\/ncb0502-e131"},{"key":"2020021218073164000_REF68","doi-asserted-by":"crossref","unstructured":"Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer.2002;2: 489-501.","DOI":"10.1038\/nrc839"},{"key":"2020021218073164000_REF69","doi-asserted-by":"crossref","unstructured":"Shield MJ. Novel applications of misoprostol. Pharmacol Ther.1995;65: 125-147.","DOI":"10.1016\/0163-7258(94)00060-G"},{"key":"2020021218073164000_REF70","unstructured":"Vane J, O'Grady J. Therapeutic applications of prostaglandins. Sevenoaks, United Kingdom: Edward Arnold, Hodder Stroughton Publishers; 1993."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/4\/1750\/1706772\/zh800405001750.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/4\/1750\/1706772\/zh800405001750.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T20:09:03Z","timestamp":1624738143000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/4\/1750\/20377\/15Deoxy%CE%941214prostaglandin-J2-induces-apoptosis-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,15]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,2,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-04-1360","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,15]]}}}